Concepedia
Statistics
Publications
12
Citations
1.3K
H-Index
Active since
2004
Affiliations
Dana-Farber Cancer Institute(Current)
Brigham and Women's Hospital
Massachusetts General Hospital
Harvard University
Dana-Farber Brigham Cancer Center
Ann Michelini is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and chemotherapy.
Publications per year
2004–2007
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
Matthew H. Kulke, Keith Stuart, Peter C. Enzinger et al. · Journal of Clinical Oncology · 2006 · 518 citations
Medicine, Oncology, Pharmacotherapy +16
Phase II Study of Recombinant Human Endostatin in Patients With Advanced Neuroendocrine Tumors
Matthew H. Kulke, Emily K. Bergsland, David P. Ryan et al. · Journal of Clinical Oncology · 2006 · 174 citations · Full text
Medicine, Oncology, Pharmacology +11
Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer
Shuji Ogino, Jeffrey A. Meyerhardt, Mami Cantor et al. · Clinical Cancer Research · 2005 · 157 citations
Medicine, Oncology, Pharmacology +15
Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer
Jeffrey A. Meyerhardt, Andrew X. Zhu, Peter C. Enzinger et al. · Journal of Clinical Oncology · 2006 · 104 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
A Phase II Trial of Irinotecan and Cisplatin in Patients with Metastatic Neuroendocrine Tumors
Matthew H. Kulke, Bingyan Wu, David P. Ryan et al. · Digestive Diseases and Sciences · 2006 · 90 citations
Medicine, Oncology, Pharmacology +14
1–5 of 12